Skip to main content
SpringerLink
Log in

Does endogenous dopamine modulate human sympathetic activity through DA2 receptors?

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of placebo and DA2 antidopaminergic agents on basal and stimulated catecholamine (CA) plasma levels in humans have been evaluated by administration either of domperidone or metoclopramide to separate groups of subjects. The latter group was subjected domperidone to sympathetic stimulation by handgrip coldpressor tests, and standing. Pharmacological DA2 receptor blockade, either peripheral by or central and peripheral by metoclopramide, did not modify plasma CA whilst resting or during acute sympathetic stimulation. It is concluded that endogenous dopamine does not seem to play a significant role in modulating NE release in man, at least not under the physiological conditions examined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Galzin AM, Dubocovich ML, Langer SZ (1982) Pre-synaptic inhibitory dopamine-like receptors on noradrenergic nerve terminals of the rabbit hypothalamus. J Pharmacol Exp Ther 221: 461–471

    Google Scholar 

  2. Mc Culloch MW, Rand MJ, Story DF (1973) Evidence for a dopaminergic mechanism for modulation of adrenergic transmission in the rabbit ear artery. Br J Pharmacol 49: 141–145

    Google Scholar 

  3. Dubocovich ML, Langer SZ (1980) Dopamine and alpha-adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors. J Pharmacol Exp Ther 212: 144–152

    Google Scholar 

  4. Enero MA, Langer SZ (1975) Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane. Naunyn Schmiedebergs Arch Pharmacol 289: 179–203

    Google Scholar 

  5. Hope W, McCulloch MW, Story DF, Rand MJ (1977) Effects of pimozide on noradrenergic transmission in rabbit isolated ear arteries. Eur J Pharmacol 46: 101–111

    Google Scholar 

  6. Fuder H, Musholl E (1978) The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation. Naunyn Schmiedebergs Arch Pharmacol 305: 109–115

    Google Scholar 

  7. Langer SZ, Dubocovich ML (1979) Physiological and pharmacological role of the regulation of noradrenaline release by presynaptic dopamine receptors. In: Imbs JL, Schwartz J (eds) Peripheral dopaminergic receptors. Pergamon Press, Oxford, pp 223–245

    Google Scholar 

  8. Lockhandwala MF, Bukley JP (1978) Effects of L-dopa on peripheral sympathetic nerve function: Role of presynaptic dopamine receptors. J Pharmacol Exp Ther 204: 362–371

    Google Scholar 

  9. Lockhandwala MF, Jandyala BS (1979) The role of sympathetic nervous system in the cardiovascular action of dopamine. J Pharmacol Exp Ther 210: 120–126

    Google Scholar 

  10. Langer SZ 1981 Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32: 337–362

    Google Scholar 

  11. Ziegler MG, Lake CR, Williams AC, Teychenne PF, Shoulson I, Stenisland O (1979) Bromocriptine inhibits norepinephrine release. Clin Pharmacol Ther 25: 137–142

    Google Scholar 

  12. Stjarne L, Brundin J (1975) Affinity of noradrenaline and dopamine for neural receptors mediating negative feedback control of noradrenaline secretion in human vasoconstrictor nerves. Acta Physiol Scand 95: 89–94

    Google Scholar 

  13. Long JP, Heintz S, Cannon JG, Kim J (1975) Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylaminotetralin (M-7), apomorphine and dopamine. J Pharmacol Exp Ther 192: 336–342

    Google Scholar 

  14. Starke K, Taube HD, Borowski E (1977) Presynaptic receptor system in catecholaminergic transmission. Biochem Pharmacol 26: 259–268

    Google Scholar 

  15. Cavero I, Massingham R, Lefevre-Borg F (1982) Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I: Subclassification and functional description. Life Sci 31: 939–948

    Google Scholar 

  16. Cavero I, Lefevre-Borg F, Gomeni R (1981) Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: Evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow. J Pharmacol Exp Ther 219: 510–512

    Google Scholar 

  17. Nilsson A, Hoekfelt B (1978) Effect of dopamine agonist bromocriptine on blood pressure, catecholamines and renin activity in acromegalics at rest, following exercise and during insulin induced hypoglycemia. Acta Endocrinol 88 [Suppl 216] (Copenh) 83–96

    Google Scholar 

  18. Kolloch R, Kobayashi K, DeQuattro V (1980) Dopaminergic control of sympathetic tone and blood pressure: Evidence in primary hypertension. Hypertension 2: 390–394

    Google Scholar 

  19. Whitfield L, Sowers JE, Tuck ML, Golub MS (1980) Dopaminergic control of plasma catecholamine and aldosterone response to acute stimuli in normal man. J Clin Endocrinol Metab 51: 724–729

    Google Scholar 

  20. Sowers JR (1981) Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension. J Clin Endocrinol Metab 53: 1133–1137

    Google Scholar 

  21. Van Loon GR, Sole MJ, Bain J, Ruse JL (1979) Effects of bromocriptine on plasma catecholamines in normal men. Neuroendocrinology 28: 425–434

    Google Scholar 

  22. Carey RM, Van Loon GR, Baines AD, Kaiser DL (1983) Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocriptine in man. J Clin Endocrinol Metab 56: 595–602

    Google Scholar 

  23. Libet B (1977) The role SIF cells play in ganglionic transmission. Adv Biochem Psycopharmacol 16: 541–546

    Google Scholar 

  24. Neff NH, Karoum F, Hadjiconstantinou M (1983) Dopamine-containing small fluorescent cells and sympathetic ganglion function. Fed Proc 42: 3009–3011

    Google Scholar 

  25. Mannelli M, Delitala G, DeFeo ML, Maggi M, Cuomo S, Piazzini M, Guazzelli R, Serio M (1984) Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. J Clin Endocrinol Metab 59: 74–78

    Google Scholar 

  26. Lackovic Z, Kleinman J, Karoum F, Neff NH (1981) Dopamine and its metabolites in human peripheral nerves: is there a widely distributed system of peripheral dopaminergic nerves? Life Sci 29: 917–922

    Google Scholar 

  27. Lackovic Z, Neff NH (1983) Evidence that dopamine is a neurotransmitter in peripheral tissues. Life Sci 32: 1665–1674

    Google Scholar 

  28. Lackovic Z, Relja M, Neff NH (1982) Catabolism of endogenous dopamine in peripheral tissues: Is there an independent role for dopamine in peripheral neurotransmission? J Neurochem 38: 1453–1458

    Google Scholar 

  29. Snider SR, Kuchel O (1983) Dopamine: An important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension. Endocr Rev 4: 291–309

    Google Scholar 

  30. Wanquier A, Niemegeers CJE, Janssen PAJ (1981) Neuropharmacological comparison between domperidone and metoclopramide. Jpn J Pharmacol 31: 305–314

    Google Scholar 

  31. Kohli JD, Glock D, Goldberg LI (1983) Selective DA2 versus DA1 antagonist activity of domperidone at the periphery. Eur J Pharmacol 89: 137–141

    Google Scholar 

  32. Neri Serneri GG, Masotti G, Gensini GF, Poggesi L, Abbate R, Mannelli M (1981) Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation? Cardiovasc Res 15: 287–295

    Google Scholar 

  33. Passon PG, Peuler JD (1973) A simplified radiometric assay for plasma norepinephrine and epinephrine. Anal Biochem 51: 618–631

    Google Scholar 

  34. Van Loon GR (1983) Plasma dopamine: Regulation and significance. Fed Proc 42: 3012–3018

    Google Scholar 

  35. Alicandri C, Agabiti-Rosei E, Corea L, Fariello R, Miele N (1977) Pressione arteriosa e catecolamine plasmatiche dopo metoclopramide in soggetti normali e ipertesi. Boll Soc Ital Cardiol 22 [8]: 1421–1426

    Google Scholar 

  36. Wilson TA, Kaiser DL, Carey RM (1983) Dopaminergic inhibition of aldosterone secretion is independent of the autonomic nervous system. J Clin Endocrinol Metab 57: 200–203

    Google Scholar 

  37. Carey RM, Thorner MO, Ortt EM (1979) Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. J Clin Invest 63: 727–735

    Google Scholar 

  38. Gilchrist NL, Espiner EA, Nicholls MG, Donald RA (1984) Effect of metoclopramide on aldosterone regulatory factors in man. Clin Endocrinol 21: 1–4

    Google Scholar 

  39. Robertson D, Garland AJ, Robertson RM, Nies AS, Shand DG, Oates JA (1979) Comparative assessment of stimuli that release neural and adrenomedullary catecholamines in man. Circulation 59: 637–643

    Google Scholar 

  40. Christensen NJ (1983) Sympathetic nervous activity during exercise. Ann Rev Physiol 45: 139–153

    Google Scholar 

  41. Gustafson AB, Kalkhoff RK (1982) Influence of sex and obesity on plasma catecholamine response to isometric exercise. J Clin Endocrinol Metab 55: 703–708

    Google Scholar 

  42. Barnes TRE, Braude WM, Hill DJ (1982) Acute akathisia after oral droperidol and metoclopramide preoperative medication. Lancet 2: 48–49

    Google Scholar 

  43. Jungmann E, Schoeffling K (1982) Akathisia and metoclopramide. Lancet 2: 221

    Google Scholar 

  44. Plouin PF, Menard J, Corvol P (1976) Hypertensive crisis in patients with pheochromocytoma given metoclopramide. Lancet 2: 1357–1358

    Google Scholar 

  45. Agabiti-Rosei E, Alicandri Cl, Corea L (1977) Hypertensive crisis in patients with pheochromocytoma given metoclopramide. Lancet 1: 600

    Google Scholar 

  46. Abe M, Orita Y, Nakashima, Nakamura M (1984) Hypertensive crisis induced by metoclopramide in patient with pheochromocytoma. Angiology 35: 122–128

    Google Scholar 

  47. Corvol P, Bisseliches F, Alexandre JM, Bohuon C, Heurtault JP, Menard J, Tcherdakoff P, Vaysse JC, Milliez P (1973) Pousses hypertensives declenchees par la sulpiride. Ann Med Interne 8–9: 647–649

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology Service USL, Florence, Italy

    M. Mannelli

  2. Endocrinology Unit University of Florence, Italy

    M. L. De Feo, M. Maggi, G. Giusti & M. Serio

  3. Medical Clinic, University of Pisa, Pisa, Italy

    A. Salvetti

Authors
  1. M. Mannelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. L. De Feo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Maggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Salvetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Giusti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Serio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mannelli, M., De Feo, M.L., Maggi, M. et al. Does endogenous dopamine modulate human sympathetic activity through DA2 receptors?. Eur J Clin Pharmacol 29, 159–164 (1985). https://doi.org/10.1007/BF00547415

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00547415

Key words

Search

Navigation